About Us
Founded in 2023 in Hangzhou, China.
The team is youthful, passionate, and highly skilled, with extensive experience in drug research and development. Our profound understanding of pathological mechanisms, combined with collaborations with cutting-edge AI drug discovery platforms and advanced pharmaceutical companies, facilitates highly effective and low-risk research and development of medical solution and novel drugs.
Pipeline Products
Each project has potential to be developed as an independent technical area with a wide range of products.
OUR VISION
Explore uncharted territories in medicine to create a healthy and beautiful world.
Main Business
- Several early-stage projects are currently in the planning stage, including tumor, chronic fibrotic diseases, hyperuricemia drugs; therapeutic vaccine for rhinitis, autoimmune diseases
- Future main business segments are: 1.Novel small molecules drugs; 2.Vaccines (Preventive vaccines for infections and therapeutic vaccines for allergies and autoimmune diseases)
Cooperation
Through successful collaboration, QianDai has built broad and consolidated alliance with universities, research centers, production and marketing facilities, drug chain management and drug sales plateform. Each partnership continues to bring us closer toward our mission and turn our strategic vision into realities.
Get In Touch
Contact Us
Hangzhou Qiandai Biotechnology Co. Ltd